Zhou, Y.; Zhou, Y.; Wang, K.; Li, T.; Zhang, M.; Yang, Y.; Wang, R.; Hu, R.
ROCK2 Confers Acquired Gemcitabine Resistance in Pancreatic Cancer Cells by Upregulating Transcription Factor ZEB1. Cancers 2019, 11, 1881.
https://doi.org/10.3390/cancers11121881
AMA Style
Zhou Y, Zhou Y, Wang K, Li T, Zhang M, Yang Y, Wang R, Hu R.
ROCK2 Confers Acquired Gemcitabine Resistance in Pancreatic Cancer Cells by Upregulating Transcription Factor ZEB1. Cancers. 2019; 11(12):1881.
https://doi.org/10.3390/cancers11121881
Chicago/Turabian Style
Zhou, Yang, Yunjiang Zhou, Keke Wang, Tao Li, Minda Zhang, Yunjia Yang, Rui Wang, and Rong Hu.
2019. "ROCK2 Confers Acquired Gemcitabine Resistance in Pancreatic Cancer Cells by Upregulating Transcription Factor ZEB1" Cancers 11, no. 12: 1881.
https://doi.org/10.3390/cancers11121881
APA Style
Zhou, Y., Zhou, Y., Wang, K., Li, T., Zhang, M., Yang, Y., Wang, R., & Hu, R.
(2019). ROCK2 Confers Acquired Gemcitabine Resistance in Pancreatic Cancer Cells by Upregulating Transcription Factor ZEB1. Cancers, 11(12), 1881.
https://doi.org/10.3390/cancers11121881